As of 2025-12-16, the Relative Valuation of Rhythm Pharmaceuticals Inc (RYTM) is (50.14) USD. This relative valuation is based on P/E multiples. With the latest stock price at 112.52 USD, the upside of Rhythm Pharmaceuticals Inc based on Relative Valuation is -144.6%.
The range of the Relative Valuation is (37.46) - (63.17) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 21.9x | 17.3x |
| Forward P/E multiples | 13.0x - 28.4x | 17.5x |
| Fair Price | (37.46) - (63.17) | (50.14) |
| Upside | -133.3% - -156.1% | -144.6% |
| Date | P/E |
| 2025-12-15 | -39.05 |
| 2025-12-12 | -39.41 |
| 2025-12-11 | -40.82 |
| 2025-12-10 | -36.36 |
| 2025-12-09 | -34.95 |
| 2025-12-08 | -36.50 |
| 2025-12-05 | -36.30 |
| 2025-12-04 | -36.68 |
| 2025-12-03 | -36.31 |
| 2025-12-02 | -35.18 |
| 2025-12-01 | -36.45 |
| 2025-11-28 | -37.86 |
| 2025-11-26 | -37.28 |
| 2025-11-25 | -37.74 |
| 2025-11-24 | -36.98 |
| 2025-11-21 | -35.31 |
| 2025-11-20 | -34.93 |
| 2025-11-19 | -35.79 |
| 2025-11-18 | -34.88 |
| 2025-11-17 | -34.94 |
| 2025-11-14 | -34.50 |
| 2025-11-13 | -33.28 |
| 2025-11-12 | -33.98 |
| 2025-11-11 | -34.65 |
| 2025-11-10 | -33.88 |
| 2025-11-07 | -34.81 |
| 2025-11-06 | -34.18 |
| 2025-11-05 | -34.52 |
| 2025-11-04 | -36.43 |
| 2025-11-03 | -39.47 |
| 2025-10-31 | -39.48 |
| 2025-10-30 | -38.80 |
| 2025-10-29 | -39.52 |
| 2025-10-28 | -39.37 |
| 2025-10-27 | -38.71 |
| 2025-10-24 | -38.33 |
| 2025-10-23 | -37.87 |
| 2025-10-22 | -37.88 |
| 2025-10-21 | -37.18 |
| 2025-10-20 | -39.00 |
| 2025-10-17 | -38.27 |
| 2025-10-16 | -38.58 |
| 2025-10-15 | -37.95 |
| 2025-10-14 | -36.51 |
| 2025-10-13 | -34.97 |
| 2025-10-10 | -34.99 |
| 2025-10-09 | -34.77 |
| 2025-10-08 | -34.78 |
| 2025-10-07 | -34.64 |
| 2025-10-06 | -33.96 |